Evidence map›Paper›PMID 28821598›Full record

GuidelineGut2017

Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS).

Sabina Beg, Krish Ragunath, Andrew Wyman, Matthew Banks, Nigel Trudgill, D Mark Pritchard, Stuart Riley, John Anderson, Helen Griffiths, Pradeep Bhandari and 2 more

Erratum issued 2 registry-linked trialsAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Gut, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 155 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04843397 unknown statusnot on this mapstarted 2021, after this paper: background citation

PROspective Multicentre Study to Identify Diagnostic Key PERfOrmance Indicators in Upper GI Endoscopy (PROSPERO)

TypeobservationalSponsorUniversity of CambridgeRan2021 to 2022Enrolled1,000ConditionsEsophageal Cancer, Gastric Cancer, Barrett Esophagus, Gastric Atrophy
NCT06218537 nacompletednot on this mapstarted 2024, after this paper: background citation

The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy

TypeinterventionalSponsorCarol Davila University of Medicine and PharmacyRan2024 to 2024Enrolled42ConditionsUpper Gastrointestinal EndoscopyArmsTest group, Control group
3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Trial
  9. Trial
  10. Trial
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Early detection of gastrointestinal cancers in low- and middle-income countries: A risk-stratified framework and implementation roadmap.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review
  16. Article
  17. Impact of Artificial Intelligence-Assisted Endoscopy on Screening for Upper Gastrointestinal Cancer in a Large-Scale Health Screening Facility.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
    Article
  18. Article
  19. Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Sabina BegDepartment of Gastroenterology, NIHR Nottingham Digestive Diseases Biomedical Research Centre, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Krish RagunathDepartment of Gastroenterology, NIHR Nottingham Digestive Diseases Biomedical Research Centre, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Andrew WymanDepartment of Surgery, Sheffield Teaching Hospitals, Sheffield, UK.
Matthew BanksDepartment of Gastroenterology, University College London Hospitals, London, UK.
Nigel TrudgillDepartment of Gastroenterology, Sandwell General Hospital, West Bromwich, UK.
D Mark PritchardDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Stuart RileyDepartment of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK.
John AndersonDepartment of Gastroenterology, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
Helen GriffithsDepartment of Gastroenterology, Wye Valley NHS Trust, Herefordshire, UK.
Pradeep BhandariDepartment of Gastroenterology, Queen Alexandra Hospital, Portsmouth, UK.
Phillip KayeDepartment of Histopathology, Nottingham University Hospitals NHS trust, Nottingham, UK.
Andrew VeitchDepartment of Gastroenterology, New Cross Hospital, Wolverhampton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This document represents the first position statement produced by the British Society of Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, setting out the minimum expected standards in diagnostic upper gastrointestinal endoscopy. The need for this statement has arisen from the recognition that while technical competence can be rapidly acquired, in practice the performance of a high-quality examination is variable, with an unacceptably high rate of failure to diagnose cancer at endoscopy. The importance of detecting early neoplasia has taken on greater significance in this era of minimally invasive, organ-preserving endoscopic therapy. In this position statement we describe 38 recommendations to improve diagnostic endoscopy quality. Our goal is to emphasise practices that encourage mucosal inspection and lesion recognition, with the aim of optimising the early diagnosis of upper gastrointestinal disease and improving patient outcomes.

Indexed as

Barrett EsophagusCeliac DiseaseChecklistClinical CompetenceEndoscopy, Digestive SystemGastrointestinal DiseasesGastrointestinal NeoplasmsHumansInformed ConsentPatient SafetyPatient SelectionPrecancerous Conditionsearly upper gastro-intestinal cancerkey performance indicatorsOGDquality

Identifiers

PMID28821598
PMCPMC5739858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.